PET health

PET stands for positron emission tomography. It is a medical imaging method, not a disease or a diagnosis.

PET shows how tissues are functioning. This is different from imaging that mainly shows body structure. PET can highlight areas using more or less of a particular substance, depending on the radioactive tracer used.

A tracer is a small amount of material that can be detected by a scanner. The tracer is usually injected into a vein. Some tracers may be swallowed or inhaled for specific tests.

PET is often combined with another type of imaging. PET/CT combines PET with computed tomography, which uses X-rays to show detailed anatomy. PET/MRI combines PET with magnetic resonance imaging.

Doctors may use PET when assessing cancer, heart conditions, epilepsy, memory problems, or other changes in organ function. The test cannot usually confirm a diagnosis on its own. Its findings must be considered alongside your symptoms, examination, laboratory tests, biopsies, and other imaging.

A PET tracer contains a small amount of a radioactive substance. As that substance changes, it releases particles called positrons. These interact with nearby electrons and produce energy that the scanner detects.

A computer turns the detected signals into images. Areas where more tracer collects may appear brighter, but brightness does not automatically mean disease.

A commonly used tracer is fluorodeoxyglucose, often shortened to FDG. FDG acts in a similar way to glucose, the sugar cells use for energy. Tissues that use more glucose may take up more FDG.

Cancer cells can have high FDG uptake, but so can normal organs, exercising muscles, inflammation, infection, and healing tissue. Some cancers have little FDG uptake. Other PET tracers are designed to examine particular organs, proteins, or body processes.

After receiving the tracer, you usually rest while it moves through your body. Movement, talking, eating, blood glucose levels, and some medicines can affect certain scans. Preparation instructions therefore differ by tracer and by the reason for the test.

During the scan, you lie on a table that moves through a ring-shaped scanner. You need to remain still so the images line up correctly. The imaging team may ask you to change position or briefly hold your breath.

The CT part of a PET/CT may be a low-dose scan used to position the PET images. Sometimes a more detailed CT is performed, possibly with an iodine-based contrast material. The tracer and CT contrast are different substances with different risks.

PET can provide information that structural imaging alone may not show. It may reveal changes in tissue activity before there is a clear change in size or shape.

In cancer care, PET may help show where a known cancer is located, whether it has spread, and how active certain areas appear. It may also help assess response to treatment or investigate a possible return of cancer. PET findings sometimes guide where a biopsy or radiation treatment should be directed.

Heart PET can examine blood flow or how heart muscle uses energy. This may help evaluate coronary artery disease or identify heart muscle that is still alive but not working normally.

Brain PET can show patterns of metabolism or examine specific proteins. It may contribute to an assessment of epilepsy, movement disorders, or causes of cognitive decline. PET findings do not by themselves establish the cause of memory or thinking problems.

A PET report describes uptake patterns and how they compare with expected normal activity. Terms such as increased uptake, decreased uptake, or metabolically active describe the image. They do not automatically identify what caused the finding.

PET results can be misleading when tracer uptake has more than one possible cause.

False-positive findings are areas that look concerning even though they are not caused by the condition being investigated. Infection, inflammation, recent surgery, radiation treatment, healing injuries, and active muscles can all increase FDG uptake.

False-negative findings occur when PET does not clearly show a condition that is present. This can happen with very small abnormalities, some slow-growing cancers, or tissue that does not take up much of the chosen tracer. High blood glucose can also reduce the usefulness of some FDG scans.

PET involves ionising radiation from the tracer. PET/CT also involves X-rays from the CT scan. The amount depends on the tracer, scan type, and CT technique. Your imaging team can explain the expected exposure and why the test was requested.

Pregnancy needs special consideration because radiation may reach the developing baby. If you are pregnant, might be pregnant, or discover a pregnancy after the scan, tell the imaging service promptly. This is usually a discussion with the service rather than an emergency.

Some tracers can enter breast milk. Instructions about pausing breastfeeding depend on the exact tracer. Ask the nuclear medicine team for tracer-specific advice rather than applying a general waiting time.

Allergic reactions to PET tracers are uncommon. If CT contrast is also used, it can cause allergic-like reactions and may require extra planning for people with certain kidney problems. These concerns relate to the contrast, not to PET itself.

Call emergency services if you develop trouble breathing, swelling of the face or throat, fainting, or another severe reaction after tracer or contrast administration. Contact the imaging service promptly for increasing pain, redness, or swelling around the injection site.

Unexpected findings may also appear in organs unrelated to the original reason for the scan. These are called incidental findings. Some need further testing, while others turn out to be harmless.

There is no home test for PET findings. Your useful actions are to prepare accurately, share relevant information, and arrange follow-up.

Before the scan:

• Ask which tracer and combined scan you will receive
• Follow the service’s instructions about food, drinks, exercise, and medicines
• Tell the team about diabetes, pregnancy, breastfeeding, allergies, and kidney problems
• Mention recent surgery, infection, vaccination, chemotherapy, or radiation treatment
• Bring details of earlier scans so images can be compared

Do not stop insulin, diabetes treatment, or other prescribed medicine unless the team responsible for the scan gives you a clear plan. If the preparation instructions conflict with your usual medical care, contact the imaging service before the appointment.

After the scan, follow any instructions about fluids, close contact with others, breastfeeding, or travel. These instructions depend on the tracer and your circumstances.

Arrange routine follow-up with the clinician who requested the scan. Useful questions include what the report found, whether the result changes your care, and whether another test or biopsy is needed. Keep a copy of the report and the date, type, and location of the scan.

Does a bright area on PET mean cancer?

No. Increased uptake may occur with cancer, but also with infection, inflammation, healing, and normal organ activity. The location, pattern, tracer, and other test results help determine what it may mean.

Is PET the same as CT?

No. PET maps biological activity. CT uses X-rays to show body structure. PET/CT combines both types of information in one examination.

Will I feel the radiation?

No. Radiation from the tracer cannot be felt. You may feel the needle used for the injection, and CT contrast can briefly cause warmth or a metallic taste.

Can I be radioactive after the test?

A small amount of radioactive tracer remains temporarily and decreases over time. The imaging service may give short-term precautions based on the tracer used. Follow those specific instructions.

Why might a scan need to be repeated?

Repeat imaging may be needed if movement blurred the pictures, preparation affected tracer uptake, equipment problems occurred, or clinicians need to compare tissue activity over time. A repeat request does not by itself mean that a condition has worsened.

When will I receive the result?

The scan must be interpreted by a nuclear medicine physician or radiologist. Timing differs between services and according to clinical urgency. Ask the imaging department when the report should reach the clinician who requested it.